Skip to content

The effect of decision aid in patients with breast cancer

The effect of decision aid package on selecting therapeutic option and decision outcomes among patients with early stage breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201210165987N6
Enrollment
30
Registered
2013-06-13
Start date
2012-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention 2: Intervention group at the first visit after confirm the diagnosis by physician, to get decision aid package were referred to the research nurse. Decision aid Package in
Intervention 2: Intervention group at the first visit after confirm the diagnosis by physician, to get decision aid package were referred to the research nurse. Decision aid Package includes a informa
Intervention 2: The control group were received routine care. Decision aid package was not given to this group. One to four days after the first visit (before beginning treatment) treatment option an

Sponsors

Vice chancellor for research, Faculty of Nursing and Midwifery, Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 78 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all case studies will sign an informed consent, and also they should have the following conditions: 1) Have clinical stage 1 or 2 breast cancer that be approved by the physician 2) Not have previous history of cancer. 3) Not have serious non-malignant diseases such as cardiovascular, respiratory, renal, which may prevent definitive surgery . 4) They should be literate. 5) They should have language of Persian dialects. 6) Not have mental disorder and addictions which preventing decision-making process and giving informed consent for participating in this study. Exclusion criteria: In this study, if a patient has one of following characteristics, it will be excluded from the study: 1) If patient requires to intensive care. 2) If patient dies or migrate (so that access to the patient is not possible). 3) If patient participate in other studies

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Select therapeutic option. Timepoint: One to four days after intervention. Method of measurement: O'Connor questionnaire.;??Decision conflict. Timepoint: 1-4 days after intervention. Method of measurement: O'Connor traditional decisional conflict scale.

Secondary

MeasureTime frame
Decision Regret. Timepoint: Eight weeks after intervention. Method of measurement: O'Connor Decision Regret Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyede Narjess Mousavizade

International Campus, Tehran University of Medical Sciences

mousavi201089@yahoo.com+98 21 6637 7579

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026